ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,703, issued on July 22.
"Homogeneous ophthalmic composition" was invented by Randal Davis (Chattanooga, Tenn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This application is directed to a homogeneous solution of an aqueous, topical composition useful for the treatment of infection and/or for the treatment of inflammation due to trauma to tissue. Specifically, this application relates to a homogeneous, aqueous composition of a quinolone antibiotic and an anti-inflammatory agent."
The patent was filed on March 29, 2022, under Application No. 17/707,913.
*For further information, including images, charts and tables, please visit: http://patft.uspt...